Now entering its third cycle, the ASH Global Research Award was created especially for trainees and early- career investigators based in countries outside of the United States and Canada. It is intended to support these hematologists during the critical period between completion of training and the establishment of their independent careers — perhaps one of the most challenging periods for these individuals. But in addition to funding (up to $100,000 for projects ≤ 1 year; up to $150,000 for projects > 1 year), the award has some unique and far-reaching underlying goals: to expand the reach of academic hematology and contribute to the development of meaningful scientific research around the world.

When the award was launched in 2017, program co-chair Ruben Mesa, MD, took note of what makes the program stand out. “This award is distinct from other ASH programs in its breadth and scope, offering at a global level some of the opportunities previously only available in the United States and Canada,” he said.

Looking back, Dr. Mesa is optimistic about the program and cites its progress over the past two years. “The first two cycles of this award have been a great success, with deep levels of interest from around the world. We have seen highly meritorious applications across a diverse spectrum of investigators — geographically, across countries of all levels of UN HDI and resources, and across malignant and nonmalignant hematology,” Dr. Mesa said. He is quite proud of the number of applicants (59 to date) and their representation of more that 25 countries. And in terms of funding, the award has provided $2.4 million in support across those first two cohorts. “We are excited by the strong interest in this new award and look forward to even further expanding the awareness and number of countries involved.”

Back in 2017 when the program first launched, the co-chairs, including Dr. Mesa, focused a great deal of effort on building awareness and on ensuring a broad range of applicants, particularly those from developing nations. “We are pleased that all these goals were met,” Dr. Mesa commented, “and that despite the heterogeneity of global differences on issues such as protected time, variable resources, and different institutional structures, the conduct of the research for awarded grants has gone very well.”

Looking ahead now, Dr. Mesa is helping the Society to build upon the long-term vision for this award — to increase tools to foster a global hematology community as well as a community among the program alumni. “We look to further expand applications from countries where we have not yet seen applications,” he said. Dr. Mesa also spotlights ongoing efforts to further awareness of the award, including at educational venues such as the Clinical Research Training Institute in Latin America and Asia and Highlights of ASH in various regions.

To learn more about the program, visit www.hematology.org/Global-Research.

2019 ASH Global Research Award cohort

ASH congratulates the 2019 ASH Global Research Award cohort of nine hematologists from four continents:

Eugenia Asare, MBChB
Ghana Institute of Clinical Genetics/Korle-Bu Teaching Hospital
Accra, Ghana

Maddalena Casale, MD, PhD
University of Campania Luigi Vanvitelli
Naples, Italy

Pedro Henrique de Lima Prata, MD
Faculdade de Medicina de Ribeirao Preto
Ribeirão Preto, São Paulo, Brazil

Chao Fang, PhD
Huazhong University of Science and Technology
Wuhan, Hubei, China

Kohei Hosokawa, MD, PhD
Kanazawa University
Kanazawa, Ishikawa, Japan

Antonija Jurak Begonja, PhD
University of Rijeka
Rijeka, Croatia

Marketa Kubricanova Zaliova, MD, PhD
Second Faculty of Medicine, Charles University
Prague, Czech Republic

Hiroyoshi Kunimoto, MD, PhD
Yokohama City University Graduate School of Medicine
Kanagwa, Yokohama, Japan

Ruth Namazzi, MD
Makerere University
Kampala, Uganda

Share This